• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT Back to Search Results
Model Number HERO 1002
Device Problem Insufficient Information (3190)
Patient Problem No Code Available (3191)
Event Type  Injury  
Event Description
According to the published paper "outcomes comparison of hero and lower extremity arteriovenous grafts in patients with long-standing renal failure," one hero patient developed upper extremity steal syndrome following hero insertion and was treated on the first postoperative day with a 4-mm eptfe interposition at the arterial anastomosis.
 
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Manufacturer Narrative
According to the published paper "outcomes comparison of hero and lower extremity arteriovenous grafts in patients with long-standing renal failure," one hero patient developed upper extremity steal syndrome following hero insertion and was treated on the first postoperative day with a 4-mm eptfe interposition at the arterial anastomosis.Additional information regarding the hero patient was requested on 04/15/2015 from the leading author of the publication.The specific information requested included the following: date of implant, date of steal syndrome, success of the intervention, patient comorbidities, current status of the patient, and the lot number.The surgeon replied on 04/26/2015 stating, "i've been trying to find some of the data, however with the study being completed 3 years ago i haven't had any success.In addition, after data collection, the database was de-identified in standard fashion.With my involvement being so long ago, i'm afraid i can't recall any of the specifics that you're asking." a manufacturing record review could not be performed as lot numbers were unavailable.The hero graft instructions for use (ifu) lists vascular insufficiency due to steal syndrome as a potential complication that ranges from 2.6% to 3.8% with hero and 3.8% in other arteriovenous grafts (avgs).Steal syndrome is not unique to the hero graft and is a well-known complication of arteriovenous access conduits; fistula, prosthetic, biologic, and xenograft inclusive.Banding procedures are well established treatments to relieve steal syndrome, as was done in this situation.Steal syndrome is a known complication of the hero device caused by shunting of blood into the venous system.This complication does not reflect a defect in the device itself and adequate precautions are provided in the ifu.
 
Event Description
According to the published paper "outcomes comparison of hero and lower extremity arteriovenous grafts in patients with long-standing renal failure," one hero patient developed upper extremity steal syndrome following hero insertion and was treated on the first postoperative day with a 4-mm eptfe interposition at the arterial anastomosis.This mdr is being filed under hero 1002.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key4694688
MDR Text Key16864631
Report Number1063481-2015-00047
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K124039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/15/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberHERO 1002
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/06/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
-
-